Welcome!
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.
Article and Video CATEGORIES
Denise has over 30 years of varying experience in the healthcare arena. In August 2009 she joined The Global Resource for Advancing Cancer Education as one of its first employees. She has grown with the organization and now oversees the operational movement of programs, efficiency, and effectiveness within the organization, as well as the daily processes and functions.
JOIN GRACE - Live in Seattle, November 10, 2018 ~Local Therapies for Metastatic Lung Cancer
dbrock
Join GRACE and Swedish Cancer Institute in Seattle for our 2018 OncTalk -- Local Therapies for Metastatic Lung Cancer
Who, What, Why, When and How?
Who, What, Why, When and How?
Image
The Global Resource for Advancing Cancer Education (GRACE)
in partnership with
Swedish Cancer Institute
presents:
Local Therapies for Metastatic Lung Cancer
Who, What, Why, When and How?
Swedish Cancer Center, Tesh Conference Room
Saturday, November 10, 2018 | 10:00 am– 1:00 pm
Join GRACE and Swedish Cancer Institute for our live event featuring Drs H. Jack West, Eric Vallieres, Vivek Mehta, Puneeth Iyengar.
In this 2018 OncTalk series, the docs will discuss local therapies for metastatic lung cancer. To view the full AGENDA, please visit this link.
Please register to join us in person at Swedish Medical Center, or join the live webcast.
Don't miss out. This event is free but space is limited! Reserve your spot!
To register please click here.
Our faculty will discuss the following topics:
- Newer Technologies in Radiation
- Novel Indications for Local Therapy in Advanced NSCLC
- The Growing Potential Utility of Surgery in Advanced NSCLC
- Systemic Therapies for Advanced NSCLC
- Panel Discussion and Question and Answer time.
Join us after for coffee and tea, and light snacks. 
To view the full agenda, please visit this link.
Please feel free to offer comments and raise questions in our
discussion forums.
Related Content
Image
Article
Tell your story and help us help others! Apply online now for this paid opportunity. This program gives a voice to those who have experience in participating in a clinical trial for a cancer diagnosis. Your voice helps to educate and advocate for others who are in or who may be considering a clinical trial. We want to hear from you!
Image
Video
The Foro de Pacientes de Terapias Dirigidas de Cáncer de Pulmón presentado el 9 de agosto de 2025 has now ended.
¡Los vídeos están disponibles BAJO DEMANDA!
Las versiones completas sin editar del Foro de Pacientes de Terapias Dirigidas de Cáncer de Pulmón de agosto de 2025 ya están disponibles BAJO DEMANDA. Estos temas se editarán y se ofrecerán en forma de vídeos más cortos en las próximas semanas.
Image
Article
Da click aquí para más información y para registrarte ahora
Online Community
Hi app.92, Welcome to Grace. I'm sorry this is late getting to you. And more sorry your mum is going through this. It's possible this isn't a pancoast tumor even though...
A Brief Tornado. I love the analogy Dr. Antonoff gave us to describe her presentation. I felt it earlier too and am looking forward to going back for deeper dive.
Dr. Singhi's reprise on appropriate treatment, "Right patient, right time, right team".
While Dr. Ryckman described radiation oncology as "the perfect blend of nerd skills and empathy".
I hope any...
My understanding of ADCs is very basic. I plan to study Dr. Rous’ discussion to broaden that understanding.
Here's the webinar on YouTube. It begins with the agenda. Note the link is a playlist, which will be populated with shorts from the webinar on specific topics
An antibody–drug conjugate (ADC) works a bit like a Trojan horse. It has three main components:
- The antibody, which serves as the “horse,” specifically targets a protein found on cancer...